Cleared Special

K130403 - MAGSTIM DOUBLE 70-2 COIL

K130403 is an FDA 510(k) clearance for MAGSTIM DOUBLE 70-2 COIL, manufactured by The Magstim Company , Ltd.. The device is a Class 2 Neurology device with product code GWF cleared through the Special 510(k) pathway after a 185-day FDA review.

K130403 · The Magstim Company , Ltd. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2013
Decision
185d
Days
Class 2
Risk

K130403 is an FDA 510(k) clearance for the MAGSTIM DOUBLE 70-2 COIL. Classified as Stimulator, Electrical, Evoked Response (product code GWF), Class II - Special Controls.

Submitted by The Magstim Company , Ltd. (Methuen, US). The FDA issued a Cleared decision on August 23, 2013 after a review of 185 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1870 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all The Magstim Company , Ltd. devices

FDA 510(k) Submission Details - K130403

510(k) Number K130403 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 19, 2013
Decision Date August 23, 2013
Days to Decision 185 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
37d slower than avg
Panel avg: 148d · This submission: 185d
Pathway characteristics
Modification to existing cleared device.

GWF Device Classification - Class 2, Special Controls

Product Code GWF Stimulator, Electrical, Evoked Response
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1870
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWF Stimulator, Electrical, Evoked Response

All 61
Devices cleared under the same product code (GWF) and FDA review panel - the closest regulatory comparables to K130403.
Neuro-IOM system with Neuro-IOM.NET software
K190703 · Neurosoft , Ltd. · May 2021
NIM Vital, Nerve Integrity Monitor
K200759 · Medtronic Xomed, Inc. · Oct 2020
The EPAD 2 System
K182542 · Safeop Surgical, Inc. · Feb 2019
MODIFCATION TO: NUVASIVE NEUROVISION EMG ENDOTRACHEAL TUBE
K094054 · Nuvasive, Inc. · May 2010
NUVASIVE NEURO VISION SYSTEM
K090298 · Nuvasive, Inc. · Jun 2009
NIM 3.0
K083124 · Medtronic Xomed, Inc. · Feb 2009